Sodium
stearyl fumarate is a monoester of fumaric acid used as a water
soluble lubricant in the development of various products such as
tablets, food products, and personal care products. Sodium stearyl
fumarate is used similarly as magnesium stearate with a same
lubrication efficiency. However, due to less hardness, and
insufficient tablets stability provided by conventional lubricating
agents, sodium stearyl fumarate come into demand. It has good
compatibility with APIs such as fluvoxamine, and a perfect lubricant
for high-performance formulations. Sodium stearyl fumarate is used in
various application such as wet granulation, dry granulation, and
direct compression. Some of the properties of sodium stearyl fumarate
include anti-adherent, hydrophilic, control particle size, lamellar
structure, less sensitivity to blending time, high consistency
compared to magnesium stearate.
Request
to view Sample Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23924
Sodium
Stearyl Fumarate Market: Drivers and Restraints
Sodium
stearyl fumarate market is witnessing maximum growth owing to its
lower hydrophobicity property which does not increase tablet
disintegration time, reduce friction, high melting point,
compatibility, solubility and an alternative to magnesium stearate.
Moreover, sodium stearyl fumarate improved drug stability, harder
tablets, faster formulation development, and faster dissolution
rates, provide protection from over blending, and enhanced
lubrication efficiency is some of the factors that can boost the
demand for sodium stearyl fumarate over the forecast period. However,
rising safety standards, clinical trials are time-consuming coupled
with significant capital investment may hamper the growth of sodium
stearyl fumarate market in near future.
Sodium
Stearyl Fumarate Market: Overview
Sodium
stearyl fumarate market revenue is expected to grow at a rapid growth
rate, over the forecast period. The market is anticipated to perform
well in the near future owing to rising demand for sodium stearyl
fumarate from pharmaceutical industry mainly from APAC, and Latin
America region. Moreover, sodium stearyl fumarate used for dough
conditioner, oxidant, wheat flour treatment agent, and offer various
advantages such as high degree of API compatibility, no adverse
effect on bioavailability, robustness to over lubrication are some of
the factors that can accelerate the market revenue growth of sodium
stearyl fumarate during the forecast period. Based on the end user,
pharmaceutical industry segment is anticipated to grow at the fastest
CAGR over the forecast period attributed to use as a lubricant in the
development of capsules, tablets and other oral dosage forms.
Buy
this Report at:
https://www.transparencymarketresearch.com/checkout.php?rep_id=23924<ype=S
Sodium
Stearyl Fumarate Market: Region-wise Outlook
Depending
on the geographic region, sodium stearyl fumarate market is divided
into seven key regions: North America, Eastern Europe, Latin America,
Western Europe, Japan, Asia-Pacific, and the Middle East &
Africa. North America held the largest revenue share in sodium
stearyl fumarate market followed by Europe, and Japan owing to
advanced technology, developed infrastructure, availability of raw
materials, and rapid organic growth by key players in these regions.
The developing nations in Asia Pacific, the Middle East and Africa
hold huge potential for growth in the sodium stearyl fumarate market
rising disposable income, expanding pharmaceutical industry in
developing countries such as India, and presence of numerous small
companies in these regions are some of the factors which strengthen
the growth of sodium stearyl fumarate market throughout the forecast
period.
Sodium
Stearyl Fumarate Market: Key Players
Some
players of sodium stearyl fumarate market are FMC Health &
Nutrition, JRS PHARMA GmbH & Co. KG, Fuji Chemical Industry Co.,
Ltd., Maruti Chemicals, TCI Chemicals (India) Pvt. Ltd., Apollo
Scientific Ltd., Gustav Parmentier GmbH, Hefei TNJ Chemical Industry
Co. Ltd., Taizhou TianRui Pharmaceutical Chemical Co., Ltd., Technoco
Co., Ltd., and others.
No comments:
Post a Comment